InnoCare Pharma Limited (HKG:9969)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.45
+0.08 (0.85%)
Apr 3, 2025, 4:08 PM HKT

InnoCare Pharma Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Operating Revenue
1,009736.99624.121,0431.36
Upgrade
Other Revenue
-1.551.28--
Upgrade
Revenue
1,009738.54625.41,0431.36
Upgrade
Revenue Growth (YoY)
36.68%18.09%-40.04%76368.70%9.38%
Upgrade
Cost of Revenue
138.44128.44143.465.67-
Upgrade
Gross Profit
871.01610.1482.01977.371.36
Upgrade
Selling, General & Admin
588.59551.01613.66436.89157.58
Upgrade
Research & Development
814.03757.25648.7721.58402.77
Upgrade
Other Operating Expenses
-10.139.7-49.841.42-
Upgrade
Operating Expenses
1,3921,3181,2131,160560.35
Upgrade
Operating Income
-521.47-708.14-730.61-182.53-558.99
Upgrade
Interest Expense
-33.79-35.21-17.38-2.64-1.14
Upgrade
Interest & Investment Income
183.97197.9136.91135.2198.58
Upgrade
Earnings From Equity Investments
-5.26---0.6-
Upgrade
Currency Exchange Gain (Loss)
--87.84-290.5657.14108.29
Upgrade
Other Non Operating Income (Expenses)
-76.04-0.38-0.82-33.42-38.61
Upgrade
EBT Excluding Unusual Items
-452.59-633.66-902.46-26.85-391.87
Upgrade
Gain (Loss) on Sale of Investments
--53.968.736.73-
Upgrade
Other Unusual Items
-43.42---
Upgrade
Pretax Income
-452.59-644.21-893.73-20.12-391.87
Upgrade
Income Tax Expense
0.261.43-46.56-
Upgrade
Earnings From Continuing Operations
-452.86-645.63-893.73-66.68-391.87
Upgrade
Minority Interest in Earnings
12.2214.377.132.130.47
Upgrade
Net Income
-440.63-631.26-886.59-64.55-391.4
Upgrade
Net Income to Common
-440.63-631.26-886.59-64.55-391.4
Upgrade
Shares Outstanding (Basic)
1,6911,7061,4781,366968
Upgrade
Shares Outstanding (Diluted)
1,6911,7061,4781,366968
Upgrade
Shares Change (YoY)
-0.90%15.46%8.15%41.21%321.19%
Upgrade
EPS (Basic)
-0.26-0.37-0.60-0.05-0.40
Upgrade
EPS (Diluted)
-0.26-0.37-0.60-0.05-0.40
Upgrade
Free Cash Flow
--920.14-860.91-2.71-423.51
Upgrade
Free Cash Flow Per Share
--0.54-0.58-0.00-0.44
Upgrade
Gross Margin
86.28%82.61%77.07%93.70%100.00%
Upgrade
Operating Margin
-51.66%-95.88%-116.82%-17.50%-40981.38%
Upgrade
Profit Margin
-43.65%-85.47%-141.76%-6.19%-28694.65%
Upgrade
Free Cash Flow Margin
--124.59%-137.66%-0.26%-31049.41%
Upgrade
EBITDA
-463.49-650.15-692.12-167.2-556.92
Upgrade
EBITDA Margin
-45.91%-88.03%-110.67%-16.03%-
Upgrade
D&A For EBITDA
57.9957.9938.4915.332.07
Upgrade
EBIT
-521.47-708.14-730.61-182.53-558.99
Upgrade
EBIT Margin
-51.66%-95.88%-116.82%-17.50%-
Upgrade
Revenue as Reported
-738.54625.4--
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.